Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Unlock the Future of Patient Recruitment: Learnings from 15 Years of Innovation

How has patient recruitment, retention, and engagement in clinical trials changed over the last 15 years, and what does the future hold?

- PMLiVE

Sanofi/Regeneron’s Dupixent granted FDA approval for chronic spontaneous urticaria

More than 300,000 people in the US are living with uncontrolled cases of the inflammatory skin disease

- PMLiVE

GSK’s Blenrep combinations approved by MHRA to treat multiple myeloma

Approximately 6,500 new cases of the blood cancer are diagnosed in the UK each year

- PMLiVE

FDA approves pre-filled syringe version of argenx’s immune disorder drug Vyvgart

The authorisation will give patients the flexibility to decide when and where they receive treatment

- PMLiVE

Coach Tolstoy

The surprising coaching lesson from Russian literature

- PMLiVE

Gut Check: A Game-Changing Experience at DDW 2025 with Medscape!

The countdown is on! The Medscape team is heading to San Diego for this year’s highly anticipated Digestive Disease Week (DDW) conference—and you won’t want to miss what we’ve got...

Medscape Education

- PMLiVE

Beyond Engagement: Creating Medical Education with Measurable Results

Want to truly engage and educate HCPs? Learn to avoid costly mistakes and be at the forefront of learning by creating a dynamic platform that captures their attention and drives...

Impetus Digital

- PMLiVE

Uniphar Secures 10th Cell and Gene Therapy Project

[Dublin, April 17th 2025] Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy (CGT) project. The milestone reinforces Uniphar’s...

Uniphar

- PMLiVE

LEO Pharma and the Parker Institute join forces to advance dermatology research

The alliance will aim to discover molecules that could be incorporated into wider pharmaceutical research

- PMLiVE

Merck and Cyprumed enter oral peptide partnership worth over $493m

The deal gives Merck access to Cyprumed’s drug delivery platform for an undisclosed number of targets

- PMLiVE

GSK’s five-in-one meningococcal vaccine recommended by CDC advisory committee

Penmenvy combines the antigenic components of GSK's approved Bexsero and Menveo vaccines

- PMLiVE

FDA grants interchangeable designation to Celltrion’s Humira biosimilar Yuflyma

The drug is approved for inflammatory conditions such as Crohn's disease and plaque psoriasis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links